TELA
Tela Bio Inc
1.10$
-4.4%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 31.0% | 31.6% | 31.7% | 31.2% | 32.2% | 36.4% | 32.4% | 30.2% | 32.5% | 34.1% | 34.3% | 27.7% | 32.2% | |
| 69.0% | 68.4% | 68.3% | 68.8% | 67.8% | 63.6% | 67.6% | 69.8% | 67.5% | 65.9% | 65.7% | 72.3% | 67.8% | |
| 15.7% | 15.8% | 14.4% | 14.4% | 10.9% | 11.5% | 13.7% | 10.9% | 11.3% | 10.2% | 12.3% | 14.1% | 11.9% | |
| 24.8% | 23.8% | 23.1% | 22.5% | 19.4% | 20.3% | 20.7% | 20.4% | 19.1% | 18.1% | 21.9% | 21.1% | 20.0% | |
| 136.7% | 140.6% | 97.3% | 140.7% | 117.2% | 110.9% | 124.1% | 114.8% | 104.0% | 97.8% | 120.9% | 120.4% | 110.4% | |
| -67.6% | -72.2% | -29.1% | -71.9% | -49.4% | -47.3% | -56.5% | -45.0% | -36.5% | -31.9% | -55.2% | -48.1% | -42.6% | |
| 8.9% | 7.9% | 8.0% | 8.3% | 7.1% | 7.3% | 6.6% | 5.9% | 5.8% | 7.8% | 10.8% | 10.8% | 8.7% | |
| -72.8% | -75.8% | -34.1% | -78.3% | -54.7% | -53.0% | -60.5% | -49.0% | -41.6% | -42.6% | -64.1% | -58.1% | -51.2% | |
| 8.9% | -27.4% | 1.1% | – | – | -0.8% | 0.3% | 0.2% | – | 0.7% | 0.3% | 0.3% | – | |
| -72.8% | -75.8% | -34.1% | -78.3% | -54.7% | -52.2% | -60.8% | -49.1% | -41.6% | -43.3% | -64.4% | -58.4% | -51.5% | |
| -62.5% | -67.0% | -24.7% | -68.5% | -46.2% | -44.2% | -52.5% | -41.7% | -34.6% | -33.7% | -51.9% | -46.8% | -41.4% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.